- Home
- SGRP vs LGVN Comparison
SGRP vs LGVN Comparison
Compare SGRP & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGRP
- LGVN
- Stock Information
- Founded
- SGRP 1967
- LGVN 2014
- Country
- SGRP United States
- LGVN United States
- Employees
- SGRP N/A
- LGVN N/A
- Industry
- SGRP Business Services
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- SGRP Consumer Discretionary
- LGVN Health Care
- Exchange
- SGRP Nasdaq
- LGVN Nasdaq
- Market Cap
- SGRP 27.8M
- LGVN 23.4M
- IPO Year
- SGRP 1996
- LGVN 2021
- Fundamental
- Price
- SGRP $1.04
- LGVN $1.35
- Analyst Decision
- SGRP
- LGVN Strong Buy
- Analyst Count
- SGRP 0
- LGVN 3
- Target Price
- SGRP N/A
- LGVN $8.67
- AVG Volume (30 Days)
- SGRP 43.2K
- LGVN 126.3K
- Earning Date
- SGRP 05-27-2025
- LGVN 05-08-2025
- Dividend Yield
- SGRP N/A
- LGVN N/A
- EPS Growth
- SGRP N/A
- LGVN N/A
- EPS
- SGRP 0.50
- LGVN N/A
- Revenue
- SGRP $228,869,000.00
- LGVN $2,225,000.00
- Revenue This Year
- SGRP N/A
- LGVN $1.30
- Revenue Next Year
- SGRP N/A
- LGVN $19.15
- P/E Ratio
- SGRP $2.14
- LGVN N/A
- Revenue Growth
- SGRP N/A
- LGVN 127.50
- 52 Week Low
- SGRP $1.00
- LGVN $0.77
- 52 Week High
- SGRP $3.12
- LGVN $6.40
- Technical
- Relative Strength Index (RSI)
- SGRP 34.96
- LGVN 40.87
- Support Level
- SGRP $1.00
- LGVN $1.30
- Resistance Level
- SGRP $1.08
- LGVN $1.52
- Average True Range (ATR)
- SGRP 0.05
- LGVN 0.13
- MACD
- SGRP 0.01
- LGVN -0.02
- Stochastic Oscillator
- SGRP 26.67
- LGVN 9.43
About SGRP SPAR Group Inc.
SPAR Group Inc is a supplier of merchandising and other marketing services. It also provides range of services to retailers, consumer goods manufacturers and distributors around the globe. The company divides its operations into three reportable regional segments: Americas, which is comprised of United States, Canada, Brazil and Mexico; Asia-Pacific (APAC), which is comprised of Japan, China, and India; and Europe, Middle East and Africa (EMEA), which is comprised of South Africa. It generates maximum revenue from Americas.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.